Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.56 EUR | -1.11% | -2.73% | -21.24% |
Apr. 02 | Shedir Pharma, into 2023 with rising revenues; profit down single digits | AN |
Mar. 29 | Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 63M 67.36M | Sales 2025 * | 67.7M 72.39M | Capitalization | 40.45M 43.25M |
---|---|---|---|---|---|
Net income 2024 * | 6M 6.42M | Net income 2025 * | 7M 7.48M | EV / Sales 2024 * | 0.42 x |
Net cash position 2024 * | 14.3M 15.29M | Net cash position 2025 * | 23.1M 24.7M | EV / Sales 2025 * | 0.26 x |
P/E ratio 2024 * |
6.03
x | P/E ratio 2025 * |
5.39
x | Employees | 79 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 12.01% |
1 day | -1.11% | ||
1 week | -2.73% | ||
Current month | -10.55% | ||
1 month | -6.81% | ||
3 months | -21.24% | ||
6 months | -21.59% | ||
Current year | -21.24% |
Managers | Title | Age | Since |
---|---|---|---|
Antonio Scala
CEO | Chief Executive Officer | 39 | 13-12-31 |
Giuseppe Somma
IRC | Investor Relations Contact | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marco Mazzarese
BRD | Director/Board Member | 45 | 18-12-31 |
Lucio Fusaro
BRD | Director/Board Member | 68 | 21-12-31 |
Umberto di Maio
FOU | Founder | 51 | 14-10-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.56 | -1.11% | 7,250 |
24-04-25 | 3.6 | +2.27% | 7,250 |
24-04-24 | 3.52 | -3.30% | 19,500 |
24-04-23 | 3.64 | 0.00% | 0 |
24-04-22 | 3.64 | -0.55% | 2,000 |
Real-time Borsa Italiana, April 26, 2024 at 11:44 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.24% | 43.82M | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- SHE Stock